|
|
Home | Submit Press Release | Advertise | Submit Website
(EMAILWIRE.COM, September 05, 2013 ) Boston, MA -- Reynolds Francis, 10% owner of Invivo Therapeutics Holdings Corp (OTC: NVIV) bought 20,000 shares of Invivo Therapeutics Holdings Corp from the open market on 09/04/2013 according to an SEC filing reported by insidercow.com at 09/04/2013 10:48:48 AM ET. The stock was up 11.35% after the InsiderCow.com report.
Trade amount: 20,000 Shares
Trade type: Open Market Buy
Price Range: 1.26 - 1.69
Transaction details can be found at http://www.insidercow.com/history/company.jsp?company=NVIV Get real-time alert on any insider trading information from www.insidercow.com, one step before everybody else.
About InsiderCow.com
InsiderCow.com is a leading real-time insider trading information provider. InsiderCow.com is the online division of InsiderCow, a privately-owned company specialized in insider trading information. InsiderCow uses its proprietary software to gather and analyze information provided by the U.S. Securities and Exchange Commission, in real-time. For more information about InsiderCow.com, visit www.insidercow.com.
About NVIV:
Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions. It intends to develop and commercialize biocompatible polymer scaffolding devices to treat acute spinal cord injuries; biocompatible hydrogel for use as dural sealants, dural replacements, and nerve conduits, as well as for local controlled release of methylprednisolone to treat spinal cord injuries and peripheral nerve injuries; and biocompatible polymer scaffolding devices seeded with autologous human neural stem cells to treat acute and chronic spinal cord injuries. The company was founded in 2005 and is headquartered in Cambridge, Massachusetts.
Disclosure: Insidercow.com is not a registered investment adviser or broker/dealer. Insidercow.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable.
InsiderCow
Kevin Leng
781-526-8657
support@insidercow.com 
Source: EmailWire.com
|
|
